Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingyou Li

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
ACS Chemical Neuroscience|September 5, 2018
Synthesis and Biological Evaluation of Fentanyl Analogues Modified at Phenyl Groups with AlkylsYajuan Qin, Luofan Ni, Jiawei Shi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationshipsKimitaka Shiotani, Anna Miyazaki, Tingyou Li, et al.
Journal of Medicinal Chemistry|May 15, 2007
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligandsTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motifTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Journal of Medicinal Chemistry|February 27, 2025
Novel Hypochlorous Acid-Activated Near-Infrared Probe Monitors the Dynamic Changes of Myeloperoxidase Activity in Ischemic BrainMeiling Sun, Yuting Wang, Huijun Xu, et al.
Pharmacology, Biochemistry, and Behavior|June 20, 2006
Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1Yunden Jinsmaa, Ewa Marczak, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3)Yoshio Fujita, Yuko Tsuda, Takashi Motoyama, et al.
Journal of Medicinal Chemistry|April 30, 2004
Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesiaYunden Jinsmaa, Anna Miyazaki, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|December 13, 2005
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonistsTingyou Li, Yoshio Fujita, Kimitaka Shiotani, et al.
Bioorganic & Medicinal Chemistry|December 5, 2006
Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonistsTingyou Li, Yunden Jinsmaa, Masahiro Nedachi, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
ACS Chemical Neuroscience|September 5, 2018
Synthesis and Biological Evaluation of Fentanyl Analogues Modified at Phenyl Groups with AlkylsYajuan Qin, Luofan Ni, Jiawei Shi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 30, 2007
Synthesis of opioidmimetics, 3-[H-Dmt-NH(CH(2))(m)]-6-[H-Dmt-NH(CH(2))(n)]-2(1H)-pyrazinones, and studies on structure-activity relationshipsKimitaka Shiotani, Anna Miyazaki, Tingyou Li, et al.
Journal of Medicinal Chemistry|May 15, 2007
Bifunctional [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues substituted at position 3 with alkylated phenylalanine derivatives yield potent mixed mu-agonist/delta-antagonist and dual mu-agonist/delta-agonist opioid ligandsTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motifTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Journal of Medicinal Chemistry|February 27, 2025
Novel Hypochlorous Acid-Activated Near-Infrared Probe Monitors the Dynamic Changes of Myeloperoxidase Activity in Ischemic BrainMeiling Sun, Yuting Wang, Huijun Xu, et al.
Pharmacology, Biochemistry, and Behavior|June 20, 2006
Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1Yunden Jinsmaa, Ewa Marczak, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3)Yoshio Fujita, Yuko Tsuda, Takashi Motoyama, et al.
Journal of Medicinal Chemistry|April 30, 2004
Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesiaYunden Jinsmaa, Anna Miyazaki, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|December 13, 2005
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonistsTingyou Li, Yoshio Fujita, Kimitaka Shiotani, et al.
Bioorganic & Medicinal Chemistry|December 5, 2006
Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonistsTingyou Li, Yunden Jinsmaa, Masahiro Nedachi, et al.
Pageof 4